Symbols / RDY $12.84 +0.55% Dr. Reddy's Laboratories Limited

Healthcare • Drug Manufacturers - Specialty & Generic • India • NYQ
RDY Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 10.72B Enterprise Value -776.82M Income 56.59B Sales 345.83B Book/sh 0.81 Cash/sh 99.20
Dividend Yield 72.00% Payout 11.82% Employees 27811 IPO — P/E 17.59 Forward P/E 23.20
PEG 3.54 P/S 0.03 P/B 15.92 P/C — EV/EBITDA -0.01 EV/Sales -0.00
Quick Ratio 1.18 Current Ratio 1.88 Debt/Eq 18.03 LT Debt/Eq — EPS (ttm) 0.73 EPS next Y 0.55
EPS Growth -14.30% Revenue Growth 4.40% Earnings 2026-05-12 ROA 7.96% ROE 16.10% ROIC —
Gross Margin 55.18% Oper. Margin 16.42% Profit Margin 16.36% Shs Outstand 832.59M Shs Float 599.16M Short Float 3.42%
Short Ratio 6.63 Short Interest — 52W High 16.17 52W Low 12.77 Beta 0.30 Avg Volume 2.15M
Volume 2.78M Target Price $14.21 Recom Hold Prev Close $12.77 Price $12.84 Change 0.55%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$291.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest RDY news

No recent news from Yahoo. Try the RSS feed for latest RDY news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category